CymaBay Therapeutics, Inc. (CBAY)
CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA.
Address
7575 GATEWAY BOULEVARD
NEWARK, CA 94560
Founded
1988
Number of Employees
101
Website
http://www.cymabay.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)